
|Videos|March 8, 2022
Dr. Rogers discusses FDA approval of InterStim X system
Author(s)Urology Times staff
The device is indicated for overactive bladder, chronic fecal incontinence, and non-obstructive urinary retention.
Advertisement
In this video, Alexandra Rogers, MD, comments on the recent FDA approval of the InterStim X system. Rogers is a urologist in Boulder, Colorado.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












